Country: Spain


Aptus Biotech is a biotechnological start-up SME founded in 2010, whose main goal is the development of new applications based on aptamer technology. We are interested in the implementation of aptamer-based tools in multiple sectors as health, biotechnology, agriculture-food industry and others. The most important objective of Aptus Biotech is the generation of value through the development of innovative diagnostic and therapeutic applications based on aptamers.

Contact person:

Main Task:

Our main goal in the project is to select aptamers against the receptor Tas1R3, a biomarker for Non-Small Cell Lung Cancer (NSCLC). APTUS is going to characterize the affinity and specificity of the selected aptamers against the target protein. Finally, Tas1R3-aptamers are going to decorate Sphingomyelin nanoemulsions to improve the interaction of the nanoparticles with metastatic cancer cells, for detection and specific treatment of occult micrometastases and improve cancer survival.